World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
17397
World Ranking
12327
National Ranking
5277

Overview

Peter J. Gough is affiliated with Inzen Therapeutics in the United States. Their research spans multiple areas within medicine, focusing on both broad and specialized fields such as immunology and microbiology.

The main fields of study in Peter J. Gough's work include:

  • Medicine
  • Immunology and Microbiology

Within these fields, the primary subfields explored consist of:

  • Immunology
  • Pulmonary and Respiratory Medicine
  • Epidemiology
  • Molecular Biology
  • Rheumatology

The research touches on a variety of interconnected topics, notably:

  • Interferon and immune responses
  • Neonatal Respiratory Health Research
  • Respiratory viral infections research
  • Respiratory Support and Mechanisms
  • Adipokines, Inflammation, and Metabolic Diseases
  • Immune Cell Function and Interaction
  • Immune cells in cancer

Recent key publications by Peter J. Gough include the following:

  • "Respiratory Syncytial Virus Infection Promotes Necroptosis and HMGB1 Release by Airway Epithelial Cells," 2020, American Journal of Respiratory and Critical Care Medicine
  • "RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice," 2020, Nature Metabolism
  • "Inactivation of RIP3 kinase sensitizes to 15LOX/PEBP1-mediated ferroptotic death," 2022, Redox Biology
  • "BindingDB Entry 50008194: Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[)," 2021, PubMed
  • "Protective Effects of Necrostatin-1 in Acute Pancreatitis: Partial Involvement of Receptor Interacting Protein Kinase 1," 2021, Cells

Peter J. Gough's research has been published in a range of venues, with frequent contributions appearing in:

  • Nature Metabolism
  • American Journal of Respiratory and Critical Care Medicine
  • Redox Biology
  • The Journal of Immunology
  • Cells

Collaborations are a notable aspect of their work. Frequent co-authors with multiple joint publications include:

  • John Bertin
  • Scott B. Berger
  • Denuja Karunakaran
  • Adam W. Turner
  • Anne-Claire Duchez

These collaborations reflect interdisciplinary efforts primarily centered around immunological and molecular biology themes. The combination of co-author expertise supports research in respiratory diseases, immune responses, and related metabolic conditions.

Best Publications

  • Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL

    William J. Kaiser;Haripriya Sridharan;Chunzi Huang;Pratyusha Mandal

  • Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death.

    Pontus Orning;Pontus Orning;Dan Weng;Dan Weng;Kristian Starheim;Kristian Starheim;Dmitry Ratner

  • MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates

    Yves Dondelinger;Wim Declercq;Sylvie Montessuit;Ria Roelandt

  • Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

    Kyle J. Garton;Peter J. Gough;Carl P. Blobel;Gillian Murphy

  • RIP3 induces apoptosis independent of pronecrotic kinase activity.

    Pratyusha Mandal;Scott B. Berger;Sirika Pillay;Kenta Moriwaki

  • Design of amidobenzimidazole STING receptor agonists with systemic activity

    J.M. Ramanjulu;G.S. Pesiridis;J. Yang;N. Concha

  • Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice

    Peter J. Gough;Ivan G. Gomez;Paul T. Wille;Elaine W. Raines

  • Neuronal Death After Hemorrhagic Stroke In Vitro and In Vivo Shares Features of Ferroptosis and Necroptosis.

    Marietta Zille;Saravanan S. Karuppagounder;Yingxin Chen;Peter J. Gough

  • Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases

    Philip A. Harris;Scott B. Berger;Jae U. Jeong;Rakesh Nagilla

  • NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling

    Yves Dondelinger;Sandrine Jouan-Lanhouet;Tatyana Divert;Emilie Theatre

  • Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice

    Scott B. Berger;Viera Kasparcova;Sandy Hoffman;Barb Swift

  • RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus

    Shoko Nogusa;Roshan J. Thapa;Christopher P. Dillon;Swantje Liedmann

  • Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death

    Dan Weng;Robyn Lynn Marty-Roix;Sandhya Ganesan;Megan K. Proulx

  • Stimulated Shedding of Vascular Cell Adhesion Molecule 1 (VCAM-1) Is Mediated by Tumor Necrosis Factor-α-converting Enzyme (ADAM 17)

    Kyle J. Garton;Peter J. Gough;Julie Philalay;Paul T. Wille

  • RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis

    Nozomi Takahashi;Lars Vereecke;Mathieu J. M. Bertrand;Linde Duprez

  • RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition

    William J. Kaiser;Lisa P. Daley-Bauer;Roshan J. Thapa;Pratyusha Mandal

  • Macrophage Class A Scavenger Receptor-Mediated Phagocytosis of Escherichia coli: Role of Cell Heterogeneity, Microbial Strain, and Culture Conditions In Vitro

    Leanne Peiser;Peter J. Gough;Tatsuhiko Kodama;Siamon Gordon

  • A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16

    Peter J. Gough;Kyle J. Garton;Paul T. Wille;Marcin Rychlewski

  • Emerging roles for ectodomain shedding in the regulation of inflammatory responses

    Kyle J. Garton;Peter J. Gough;Elaine W. Raines

  • RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.

    Kay Hänggi;Lazaros Vasilikos;Aida Freire Valls;Rosario Yerbes

Frequent Co-Authors

John Bertin
John Bertin GlaxoSmithKline (United Kingdom)
Siamon Gordon
Siamon Gordon University of Oxford
David R. Greaves
David R. Greaves University of Oxford
Elaine W. Raines
Elaine W. Raines University of Washington
Edward S. Mocarski
Edward S. Mocarski Emory University
Francis Ka-Ming Chan
Francis Ka-Ming Chan Duke University
Peter J. Dempsey
Peter J. Dempsey University of Colorado Denver
Mathieu J.M. Bertrand
Mathieu J.M. Bertrand Ghent University
Katherine A. Fitzgerald
Katherine A. Fitzgerald University of Massachusetts Chan Medical School
Jun Yu
Jun Yu Chinese University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Peter J. Gough

Trending Scientists

Recently Published Articles